Ambry Genetics to Present at 2021 ACMG Annual Clinical Genetics Meeting
Ambry Genetics to Present at 2021 ACMG Annual Clinical Genetics Meeting Study shows strong data for finding whether certain genetic variants in the BRCA2 cancer gene may be classified as disease-causing News provided by Share this article Share this article ALISO VIEJO, Calif., April 13, 2021 /PRNewswire/ -- Ambry Genetics Corporation (Ambry), a Konica Minolta Precision Medicine (KMPM) company and a leader in clinical diagnostic testing, announced it will be presenting The Uniform Application of Protein Functional Data has an Impressive Potential to Resolve VUS Rates in BRCA2 based on a ...
Source: prnewswire.com